Welcome to the Department of Microbiology

This section is composed of 15 research groups and 4 project groups. We are characterized by excellence in enabling technologies within molecular and computational biology and a strong focus on curiosity driven basic science with a track record of ground-breaking research. Fundamental discoveries of enzyme activities have inspired a wide research portfolio spanning early development to aging and implications for human disease during the entire life course.

This strong focus on fundamental research has resulted in the section being awarded a Centre of excellence, Centre for Embryology and Healthy Development (CRESCO) that started 1st July 2023.

Our research strategy is aligned with the overall aims at Oslo University Hospital and Clinic of Laboratory Medicine. In addition we have priorities in three pillars; ground-breaking research, development of talent and innovation.

Head of department: Fredrik Müller
Head of research section: Hilde Loge Nilsen

News:

News about our researchers

Research groups:

RNA/DNA base modifications

Ingrun Alseth

Stem Cells, Ageing and Cancer

Lorena Arranz

Fungal and Bacterial Infections Research Group

Jørgen V. Bjørnholt

Cellular Responses to DNA Damage

Magnar Bjørås

Cell and tissue dynamics

Stig Ove Bøe

Genome and Epigenome Regulation in Embryo Development, Ageing and Disease

John Arne Dahl

Structural Biology and DNA repair

Bjørn Dalhus

Clinical Virology Research Group 

Susanne G. Dudman

Stem Cell Dynamics and RNA Regulation

Adam A. Filipczyk

Laboratory for Dynamic Gene Regulation

Arne Klungland

Virology Research Group

Mari Kaarbø 

Genome Instability in Ageing and Disease

Hilde L. Nilsen

Targeting tumors of central nervous system

Deo Prakash Pandey

Genome Dynamics

Tone Tønjum

Bacterial Defense Systems and Antimicrobial Resistance Group

James Booth and Emily Helgesen

News

The “Oslo patient” – probably cured of HIV

Photo: Grete Hansen, Bioingeniøren
Photo: Grete Hansen, Bioingeniøren

Mari Kaarbø, leader of the Virology Research Group at Oslo University Hospital, was interviewed by the journal Bioingeniøren after leading one of the research teams that collaborated on the “Oslo patient” project. Kaarbø has been primarily responsible for the careful examination of the patient’s blood and gut cells to identify HIV reservoirs. The patient has been off treatment and clinically virus‑free for nearly three years.